• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

Our Mission

LuCE is the voice of Europeans impacted by lung cancer. We collaborate with members and other stakeholders to destigmatise the disease and ensure that those impacted by lung cancer get the care they need to achieve the best possible outcomes. We empower members to ensure strong and effective lung cancer patient advocacy across Europe.

Our Vision

All Europeans impacted by lung cancer will have equity in access to optimal care so that they have the best possible outcomes and quality of life

Our Values

Our values are to represent, strenghten, amplify and act

logo

Join Upcoming Events
Replays & Webinars

loveicon

loveicon

News

8​

January​

BMS Press Release is out now

Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]

29​

November​

Press Release: High risk of financial vulnerability after diagnosis: The majority of people impacted by lung cancer experience higher costs and reduction in income

Financial impact of lung cancer: A European perspective High risk of financial vulnerability after diagnosis:  The majority of people impacted […]

29​

November​

8th Edition of the LuCE Report – Financial impact of lung cancer: A European perspective

This is an annual initiative led by lung cancer patient organisations, across Europe with the purpose of raising awareness relating […]